Clinical Trial Update: Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral branched-chain amino acid supplementation in patients with cirrhosis and sarcopenia. The study is currently enrolling by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Sarcopenia

Drugs mentioned

• Oral branched-chain amino acid supplement (branched-chain amino acids (BCAA) supplement)

Snippet

Sponsor: Mahidol University | Conditions: Sarcopenia, Cirrhosis of the Liver | Phase 3 | Status: ENROLLING_BY_INVITATION